BACKGROUND: Surgical resection of hepatic lesions is associated with intraoperative and postoperative morbidity and mortality. Our center has introduced a laparoscopic liver resection (LLR) program over the past 3 years. Our objective is to describe the initial clinical experience with LLR, including a detailed cost analysis. STUDY DESIGN: We evaluated all LLRs from 2006 to 2010. Each was matched to 2 open cases for number of segments removed, patient age, and background liver histology. Model for End-Stage Liver Disease (MELD) and the Charlson comorbidity index were calculated retrospectively. Nonparametric statistical analysis was used to compare surgical and economic outcomes. Analyses were performed including and excluding converted cases. RESULTS: Fifty-seven patients underwent attempted LLR. Demographic characteristics were similar between groups. Estimated blood loss was lower in the LLR vs the open liver resection (OLR) group, at 250 mL and 500 mL, respectively (p < 0.001). Median operating room times were 240 minutes and 270 minutes in the LLR and OLR groups, respectively (p = 0.14). Eight cases were converted to open (14%): 2 for bleeding, 2 for anatomic uncertainty, 1 for tumor size, 1 for margins, 1 for inability to localize the tumor, and 1 for adhesions. Median length of stay was lower for LLR at 5 days vs 6 days for OLR (p < 0.001). There was no difference in frequency of ICU admission, reoperation, 30-day emergency room visit, or 30-day readmission rates. Median overall cost for LLR was lower at $11,376 vs $12,523 for OLR (p = 0.077). CONCLUSIONS: Our experience suggests that LLR confers the clinical advantages of reduced operating room time, estimated blood loss, and length of stay while decreasing overall cost. LLR, therefore, appears to be a clinically and fiscally advantageous approach in properly selected patients.
BACKGROUND: Surgical resection of hepatic lesions is associated with intraoperative and postoperative morbidity and mortality. Our center has introduced a laparoscopic liver resection (LLR) program over the past 3 years. Our objective is to describe the initial clinical experience with LLR, including a detailed cost analysis. STUDY DESIGN: We evaluated all LLRs from 2006 to 2010. Each was matched to 2 open cases for number of segments removed, patient age, and background liver histology. Model for End-Stage Liver Disease (MELD) and the Charlson comorbidity index were calculated retrospectively. Nonparametric statistical analysis was used to compare surgical and economic outcomes. Analyses were performed including and excluding converted cases. RESULTS: Fifty-seven patients underwent attempted LLR. Demographic characteristics were similar between groups. Estimated blood loss was lower in the LLR vs the open liver resection (OLR) group, at 250 mL and 500 mL, respectively (p < 0.001). Median operating room times were 240 minutes and 270 minutes in the LLR and OLR groups, respectively (p = 0.14). Eight cases were converted to open (14%): 2 for bleeding, 2 for anatomic uncertainty, 1 for tumor size, 1 for margins, 1 for inability to localize the tumor, and 1 for adhesions. Median length of stay was lower for LLR at 5 days vs 6 days for OLR (p < 0.001). There was no difference in frequency of ICU admission, reoperation, 30-day emergency room visit, or 30-day readmission rates. Median overall cost for LLR was lower at $11,376 vs $12,523 for OLR (p = 0.077). CONCLUSIONS: Our experience suggests that LLR confers the clinical advantages of reduced operating room time, estimated blood loss, and length of stay while decreasing overall cost. LLR, therefore, appears to be a clinically and fiscally advantageous approach in properly selected patients.
Authors: Francesco Di Fabio; Morsal Samim; Paolo Di Gioia; Rosemary Godeseth; Neil W Pearce; Mohammed Abu Hilal Journal: World J Surg Date: 2014-12 Impact factor: 3.352
Authors: S Wabitsch; A Kästner; P K Haber; L Feldbrügge; T Winklmann; S Werner; J Pratschke; Moritz Schmelzle Journal: Langenbecks Arch Surg Date: 2019-05-07 Impact factor: 3.445
Authors: Paolo Limongelli; Chiara Vitiello; Andrea Belli; Madhava Pai; Salvatore Tolone; Gianmattia Del Genio; Luigi Brusciano; Giovanni Docimo; Nagy Habib; Giulio Belli; Long Richard Jiao; Ludovico Docimo Journal: World J Gastroenterol Date: 2014-12-14 Impact factor: 5.742
Authors: Ioannis A Ziogas; Alexandros P Evangeliou; Konstantinos S Mylonas; Dimitrios I Athanasiadis; Panagiotis Cherouveim; David A Geller; Richard D Schulick; Sophoclis P Alexopoulos; Georgios Tsoulfas Journal: Eur J Health Econ Date: 2021-03-19
Authors: Liza Abraham; Nik Goyert; Daniel J Kagedan; Andrea MacNeill; Michelle C Cleghorn; Julie Hallet; Fayez A Quereshy; Natalie G Coburn Journal: Can J Surg Date: 2018-12-01 Impact factor: 2.089
Authors: Mohammed Abu Hilal; Francesco Di Fabio; Shareef Syed; Robert Wiltshire; Eleonora Dimovska; David Turner; John N Primrose; Neil W Pearce Journal: Surg Endosc Date: 2013-01-26 Impact factor: 4.584